Skip to main content
Abbott India Ltd. logo

Abbott India Ltd. — Investor Relations & Filings

Ticker · ABBOTINDIA ISIN · INE358A01014 LEI · 5493008KZ9E3HFRN6T46 BSE.NS Manufacturing
Open in API
Filings indexed 448 across all filing types
Latest filing 2021-12-21 Regulatory Filings
Country IN India
Listing BSE.NS ABBOTINDIA

About Abbott India Ltd.

https://www.abbott.co.in

Abbott India Ltd. is a pharmaceutical entity focused on providing high-quality healthcare solutions through a diverse portfolio of trusted brands. The company specializes in several key therapeutic areas, including women's health, gastroenterology, cardiology, metabolic disorders, primary care, and the central nervous system. Its product range features well-known formulations such as Duphaston, Thyronorm, Udiliv, Vertin, and Digene. The organization leverages advanced manufacturing capabilities and an extensive distribution network to serve healthcare professionals and patients. It emphasizes science-based innovation and clinical excellence to address evolving medical needs. By maintaining a strong focus on patient outcomes and therapeutic efficacy, the company has established itself as a reliable provider of pharmaceutical products across various specialized and general medical segments.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the issuance of a duplicate share certificate to a shareholder. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about a shareholder's request for a duplicate share certificate and the company's intention to issue it after formalities. There is no financial data, no report, no management discussion, no earnings information, or any other type of financial or governance report. This is a regulatory compliance notification related to share certificates, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2021-12-21 English
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs the stock exchange about requests from shareholders for the issuance of duplicate share certificates. The content is a regulatory notification related to share certificate issuance and does not contain financial data, management discussion, or report publication. It is not a financial report, earnings release, or management report. It is a regulatory filing informing about shareholder requests and procedural updates. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short and it is an official notification to the exchange, fitting the RNS category.
2021-12-20 English
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the issuance of a duplicate share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details a shareholder's request for a duplicate share certificate and the process to be followed. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes. This is a regulatory compliance notification related to share certificates, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like Share Issue/Capital Change or Director's Dealing. The document length is short and it is an official regulatory communication.
2021-12-15 English
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the issuance of duplicate share certificates to shareholders. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about shareholder requests for duplicate certificates and does not contain financial data, earnings, management changes, or report announcements. It is a regulatory compliance communication related to share certificates but not a financial report or announcement of voting results. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-12-09 English
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the issuance of a duplicate share certificate for a shareholder. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about a shareholder's request for a duplicate share certificate and the company's intention to issue it after formalities. This is a notification related to share certificates and does not contain financial data, management discussion, or report content. It is not an announcement of a report publication, nor is it a financial or governance report. The document fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-07 English
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the issuance of duplicate share certificates to shareholders. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about shareholder share certificate requests and does not contain financial data, earnings, management changes, or any report publication. It is an official regulatory communication related to shareholding but not a report or announcement of financial results or corporate governance changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-03 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.